Royale Manor Hotels & Industries Ltd — Important, 10-09-2025: Company Update

Here are the summaries based on your preferences:

**Royale Manor Hotels and Industries Limited**

Royale Manor Hotels and Industries will conduct its 34th Annual General Meeting via video conference, allowing shareholders to participate in key decisions. Notice of the AGM and annual reports have been sent electronically. The company is providing a remote e-voting facility for members. The register of members and share transfer books will be closed during a specified period for the meeting. Shareholders can also request a printed annual report.

**Ujjivan Small Finance Bank**

Ujjivan Small Finance Bank has outlined a strategic roadmap to achieve a Gross Loan Book of Rs. 100,000 Crore by FY30. The bank plans to significantly increase its secured loan portfolio to 65-70% through expansion in affordable housing, MSME, and vehicle finance. It also aims to grow its retail deposit base, targeting 35% CASA, supported by expanding its branch network to around 1,150. Management anticipates annual Gross Loan Book growth of 20-25%, with RoE of 16-18% and RoA of 1.8-2.0% by FY30.

**Toyota Kirloskar Motor (TKM)**

Toyota Kirloskar Motor has announced price reductions, fully passing on the benefits of recent GST rate changes to its customers. The company anticipates this move will boost sales and accelerate demand, especially ahead of the festive season. TKM emphasized its commitment to customer-centricity and making world-class mobility solutions more accessible, contributing to market growth.

**Alembic Pharmaceuticals Limited**

Alembic Pharmaceuticals has received final USFDA approval for its Phytonadione Injectable Emulsion USP, 1 mg/0.5 mL Single-Dose Prefilled Syringe. This approved drug is therapeutically equivalent to the reference listed drug and is indicated for treating hypoprothrombinemia and vitamin K-deficiency bleeding. The estimated market size for this product is US$ 44 million, offering a new revenue opportunity for the company in the US market.

**Gujarat Themis Biosyn Limited**

Gujarat Themis Biosyn is informing shareholders about a special window for re-lodging physical share transfer requests. This initiative helps investors who had previous requests rejected or returned to secure their rights. Eligible shareholders can submit their requests to the company's Registrar and Share Transfer Agent during a six-month period. All securities re-lodged for transfer will be issued in Demat mode, regularizing pending cases.